Question

Difficulty: MediumPharmacokinetic and Pharmacodynamic Principles

A 42-year-old woman is brought to the emergency department by her husband due to progressive confusion, unsteadiness, and hand tremors over the past 3 days. She has a history of bipolar disorder and has been stable on a fixed dose of lithium carbonate for the last three years. Two weeks ago, she was diagnosed with osteoarthritis of the knee and began taking a newly prescribed daily oral medication for joint pain. Her vital signs are temperature 37.0∘C37.0^\circ\text{C} (98.6∘F98.6^\circ\text{F}), blood pressure 138/85 mmHg138/85\text{ mmHg}, pulse 88/min88/\text{min}, and respiratory rate 14/min14/\text{min}. Physical examination reveals a coarse resting tremor and marked ataxia. Laboratory studies show a serum lithium concentration of 2.1 mEq/L2.1\text{ mEq/L} (therapeutic range: 0.6−1.2 mEq/L0.6-1.2\text{ mEq/L}) and a serum creatinine of 1.4 mg/dL1.4\text{ mg/dL} (baseline: 0.8 mg/dL0.8\text{ mg/dL}). The newly prescribed medication is identified as the likely cause of her current condition. Which of the following pharmacokinetic mechanisms best explains this patient's acute toxicity?

  1. Reduced glomerular filtration and enhanced proximal tubular reabsorptionAnswer
  2. B
    Competitive inhibition of hepatic cytochrome P450 isoenzymes
  3. C
    Displacement of the psychiatric medication from plasma proteins
  4. D
    Decreased apparent volume of distribution due to acute fluid shifts
  5. E
    Enhanced gastrointestinal mucosal permeability and absorption

Answer

Reduced glomerular filtration and enhanced proximal tubular reabsorption
The correct answer accurately links the physiologic effect of NSAIDs to the pharmacokinetic handling of lithium. The patient's elevated creatinine and lithium levels point to a renal interaction. NSAIDs inhibit the synthesis of vasodilatory prostaglandins, leading to vasoconstriction of the afferent arteriole. This reduces the glomerular filtration rate (GFR). In response to a lower GFR, the kidneys attempt to preserve volume by upregulating the reabsorption of sodium in the proximal tubule. Because the proximal tubule cannot distinguish well between sodium and lithium, lithium is reabsorbed alongside sodium, resulting in decreased lithium clearance and acute systemic toxicity.

Step-by-Step Solution

1
Identify the clinical syndrome and the likely offending agent.
The patient has acute lithium toxicity (tremor, ataxia, confusion, level of 2.1 mEq/L) triggered by a new medication for osteoarthritis, which is almost certainly a nonsteroidal anti-inflammatory drug (NSAID).
Connecting the new symptom onset with the osteoarthritis treatment establishes the drug-drug interaction context.
2
Determine the pharmacological effect of NSAIDs on renal physiology.
NSAIDs inhibit cyclooxygenase, decreasing prostaglandin production. Since prostaglandins normally dilate the afferent arteriole, their absence leads to afferent vasoconstriction and a decreased glomerular filtration rate (GFR).
Understanding the foundational mechanism of NSAID-induced nephrotoxicity is required to trace the pharmacokinetic impact.
3
Apply the altered renal physiology to the pharmacokinetics of lithium.
A decreased GFR triggers the kidneys to compensate by increasing sodium reabsorption in the proximal tubule. Because lithium is handled identically to sodium in this nephron segment, its reabsorption also increases, drastically reducing its clearance and causing toxic accumulation.
This confirms that reduced clearance via enhanced proximal reabsorption is the precise pharmacokinetic mechanism of the interaction.

Key Concept

NSAIDs cause lithium toxicity by inhibiting renal prostaglandin synthesis, which decreases afferent arteriolar blood flow and GFR, leading to a compensatory increase in the proximal tubular reabsorption of both sodium and lithium.
Estimated Time:1m 30s
Rate this question